RMD Open (Feb 2024)

Increased prevalence of hearing loss, tinnitus and sudden deafness among patients with Sjögren’s syndrome

  • Herng-Ching Lin,
  • Sudha Xirasagar,
  • Tzong-Hann Yang,
  • Yen-Fu Cheng,
  • Chin-Shyan Chen

DOI
https://doi.org/10.1136/rmdopen-2023-003308
Journal volume & issue
Vol. 10, no. 1

Abstract

Read online

Background This study aimed to provide an updated prevalence of hearing loss, tinnitus, vertigo and sudden deafness on patients with Sjögren’s syndrome and matched comparison patients.Methods Data for this study were retrieved from the Taiwan Longitudinal Health Insurance Database and Taiwan’s registered catastrophic illness dataset. This study included 20 266 patients with Sjögren’s syndrome as the study group and 60 798 propensity score-matched comparison patients as the comparison group. We used multivariable logistic regressions to estimate the ORs and 95% CI for tinnitus, hearing loss, vertigo and sudden deafness among Sjögren’s syndrome patients versus comparison patients.Results χ2 tests showed there were statistically significant differences between the study group and comparison group in the prevalence of tinnitus (10.1% vs 6.3%, p<0.001), hearing loss (5.6% vs 3.3%, p<0.001), vertigo (4.6% vs 3.2%, p<0.001) and sudden deafness (0.8% vs 0.6%, p<0.001). Multiple logistic regression revealed that patients with Sjögren’s syndrome had a greater tendency to have tinnitus (OR=1.690, 95% CI 1.596–1.788), sudden deafness (OR=1.368, 95% CI 1.137–1.647), hearing loss (OR=1.724, 95% CI 1.598–1.859) and vertigo (OR=1.473, 95% CI 1.360–1.597) relative to comparison patients after adjusting for age, income, geographic location, residential urbanisation level, diabetes, hypertension, hyperlipidaemia and rheumatoid arthritis.Conclusions We found higher prevalence of hearing loss, vertigo, tinnitus and sudden deafness among patients with Sjögren’s syndrome relative to comparison patients. Findings may provide guidance to physicians in counselling patients with Sjögren’s syndrome regarding a higher risk of hearing loss, tinnitus, sudden deafness and vertigo.